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The Polycomb Protein Pc2 Is a SUMO E3
plexes (Pirrotta, 1998; Jacobs and van Lohuizen, 2002).Michael H. Kagey, Tiffany A. Melhuish,
PcG complexes form discrete foci within the nucleus,and David Wotton*
which have been termed PcG bodies (Gerasimova andDepartment of Biochemistry and Molecular
Corces, 1998; Saurin et al., 1998), which are generallyGenetics
located near centromeres and may result from the cluster-Center for Cell Signaling
ing of multiple DNA-associated PcG complexes. Recruit-University of Virginia
ment of other transcriptional regulators to PcG bodiesCharlottesville, Virginia 22908
may play a role in mediating transcriptional repression
(Sewalt et al., 1999; van der Vlag and Otte, 1999; Espinas
et al., 2000; Simon and Tamkun, 2002). Recent workSummary
has demonstrated that PcG complexes contain histone
methyl transferase activity, which likely plays an impor-Polycomb group (PcG) proteins form large multimeric
tant role in transcriptional regulation (Cao et al., 2002;complexes (PcG bodies) which are involved in the sta-
Czermin et al., 2002; Kuzmichev et al., 2002; Muller etble repression of gene expression. The human PcG
al., 2002; Sewalt et al., 2002). However, much remainsprotein, Pc2, has been shown to recruit the transcrip-
to be determined with respect to the function of PcGtional corepressor, CtBP, to PcG bodies. We show that
complexes.CtBP is sumoylated at a single lysine. In vitro, CtBP
SUMO (small ubiquitin-related modifier) is similar tosumoylation minimally requires the SUMO E1 and E2
ubiquitin in terms of its structure and mechanism of(Ubc9) and SUMO-1. However, Pc2 dramatically en-
attachment to target proteins (Mayer et al., 1998;hances CtBP sumoylation. In vivo, this is likely due to
Jentsch and Pyrowolakis, 2000; Melchior, 2000). Threethe ability of Pc2 to recruit both CtBP and Ubc9 to
mammalian SUMO isoforms exist: SUMO-2 and 3, whichPcG bodies, thereby bringing together substrate and
are highly related and the more divergent SUMO-1E2, and stimulating the transfer of SUMO to CtBP.
(Boddy et al., 1996; Mannen et al., 1996; Okura et al.,These results demonstrate that Pc2 is a SUMO E3, and
1996; Shen et al., 1996; Lapenta et al., 1997). It is notsuggest that PcG bodies may be sumoylation centers.
clear whether there are important functional differences
between the three SUMOs. Indeed, the functional signifi-Polycomb group (PcG) proteins were identified in Dro-
cance of sumoylation is less well understood than thatsophila as regulators of homeotic gene expression (Ken-
of ubiquitination. Unlike poly-ubiquitination, sumoyla-nison, 1995; Simon, 1995). PcG proteins maintain the
tion of a protein does not target it for degradation, butrepressed state of these genes, and in PcG mutant flies,
may play a role in targeting proteins to specific sub-expression of homeotic genes is seen outside their nor-
cellular locations (Melchior, 2000; Hay, 2001; Muller etmal segment boundaries, resulting in altered body part
al., 2001). For example, sumoylation of PML is requiredidentity (Simon, 1995; Schumacher and Magnuson,
for its localization to PML bodies (Muller et al., 1998;1997). PcG proteins appear to act as an epigenetic mark
Lallemand-Breitenbach et al., 2001). Sumoylation ofon the chromatin template that maintains the silent state
RanGAP targets it to the nuclear pore complex (NPC)at specific target loci (Cavalli and Paro, 1998). PcG pro-
(Matunis et al., 1996). Sumoylation has also been shownteins comprise a family of functionally related proteins,
the regulate the activity of a variety of transcription fac-
many of which interact with each other to form PcG
tors including p53 and Sp3 (Rodriguez et al., 1999; Ross
complexes (Pirrotta, 1998; Sewalt et al., 1998; Francis
et al., 2002; Sapetschnig et al., 2002).
et al., 2001; Gunster et al., 2001). Conjugation of SUMO or ubiquitin to a target protein
Mammalian homologs of many Drosophila PcG pro- occurs by a similar mechanism: SUMO/ubiquitin is
teins are known (Brock and van Lohuizen, 2001), and cleaved at two conserved glycines and is then attached
it appears that multiple core PcG complexes exist in by the carboxyl-terminal residue to a lysine within the
different cell types (Sewalt et al., 1998; Francis et al., target protein (Hershko and Ciechanover, 1998; Mel-
2001; Gunster et al., 2001). Although direct DNA binding chior, 2000; Pickart, 2001). Ubiquitination involves an
of individual PcG proteins has not been demonstrated, activating enzyme (E1), a conjugating enzyme (E2), and
PcG complexes can bind to DNA (Francis et al., 2001). a ubiquitin ligase (E3) (Hershko and Ciechanover, 1998).
In addition, PcG complexes can be recruited to DNA by A single ubiquitin E1, and multiple E2 and E3 proteins
interactions with specific DNA binding proteins, includ- are known (Jackson et al., 2000). It is the E3 ligases
ing YY1, E2F, and Rb (Dahiya et al., 2001; Satijn et al., which largely determine substrate specificity. For
2001; Ogawa et al., 2002). Direct tethering of PcG pro- SUMO, a single E1 (a heterodimer of Aos1 and Uba2)
teins, such as Drosophila Pc, to DNA reveals that they and E2 (Ubc9) have been identified (Dohmen et al., 1995;
can mediate repression of gene expression (Muller, Desterro et al., 1997; Johnson and Blobel, 1997; John-
1995; Poux et al., 2001). Once recruited to DNA, PcG son et al., 1997). However, until recently, no SUMO E3
proteins appear to exert their repressive effects over ligases were known, raising the question of how speci-
large distances, either by spreading along the DNA tem- ficity is controlled.
plate, or by bringing together distant DNA-bound com- Many SUMO target proteins contain the amino acid
motif, KxE ( is hydrophobic) (Melchior, 2000). Muta-
tional and structural evidence suggest that this motif*Correspondence: dw2p@virginia.edu
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plays an important role in binding Ubc9 and directing by SDS-PAGE and Western blotted to detect T7-CtBP.
In addition to unmodified CtBP, a slower migrating bandsumoylation to the lysine (Sampson et al., 2001; Bernier-
Villamor et al., 2002). Recent evidence has demon- was also observed in the presence of H6-SUMO-1 or -3
(Figure 1B). The mobility of this band is consistent withstrated the presence of two families of SUMO E3s. In S.
cerevisiae, Siz1p is required for sumoylation of septins in the attachment of H6-SUMO to CtBP. The intensity of
the slower migrating band was clearly enhanced byvivo and enhances in vitro sumoylation (Johnson and
Gupta, 2001; Takahashi et al., 2001). Siz1p, and the coexpression of Ubc9, suggesting that Ubc9 may be
limiting. As further evidence that the slower migratingrelated Siz2p, contain a divergent RING-like motif similar
to those found in a class of ubiquitin E3s. Mammalian CtBP was sumoylated, COS-1 cells were transiently
transfected with H6-CtBP and Flag-tagged SUMO-1 orPIAS (protein inhibitor of activated STAT) proteins act
as SUMO E3s for LEF1, p53, and c-Jun (Kahyo et al., -3. Cells were lysed in 6 M guanidine-HCl and proteins
were affinity purified on cobalt agarose, separated by2001; Sachdev et al., 2001; Schmidt and Muller, 2002).
Siz and PIAS proteins share a conserved RING-like do- SDS-PAGE, and Western blotted with a Flag antibody
to detect the CtBP-conjugated SUMO. Multiple slowermain, suggesting they are members of the same family
of SUMO E3s (Hochstrasser, 2001; Jackson, 2001). migrating bands corresponding to SUMO conjugated
CtBP were observed (Figure 1C). Multiple sumoylatedRanBP2 is an NPC-associated protein which has SUMO
E3 activity toward Sp100 and a class II histone deacety- forms of CtBP were also evident by direct Western blot
of the lysates (Figure 1C, lower panel). To determinelase (Kirsh et al., 2002; Pichler et al., 2002). RanBP2 also
contains a RING domain, but it is dispensable for E3 whether CtBP was subject to SUMO modification at
endogenous expression levels, HeLa cell proteins wereactivity, suggesting that RanBP2 represents a second
class of SUMO E3s. immunoprecipitated with an antibody specific for CtBP.
When immunoprecipitates were analyzed by SDS-PAGEWe demonstrate that the transcriptional corepressor
CtBP (carboxyl-terminus binding protein) is modified by and Western blotted with a SUMO-1-specific antibody,
a band of the appropriate mobility for SUMO-1-conju-SUMO-1 or SUMO-3 on a single lysine. CtBP was identi-
fied by its interaction with the adenovirus E1A protein gated CtBP was clearly visible (Figure 1D). This band
was not detected when proteins were first immunopre-and this interaction is required for transcriptional repres-
sion by E1A (Boyd et al., 1993; Schaeper et al., 1995). cipitated with a CtBP2-specific antibody, or with a con-
trol antibody (Flag). Together, these data clearly demon-CtBP has since been shown to bind many gene-specific
and general transcriptional repressors via a PLDLS (or strate that CtBP is a substrate for sumoylation, both in
vivo and in vitro.related) motif (Schaeper et al., 1998; Turner and Cross-
ley, 1998, 2001; Chinnadurai, 2002). CtBP interacts with
Pc2, a polycomb group protein, resulting in the recruit- CtBP Is Sumoylated at Lysine 428
ment of CtBP to PcG bodies (Sewalt et al., 1999). We To determine the importance of the sumoylation motif
show that Pc2 is a SUMO E3 which recruits both CtBP surrounding lysine 428, we created a version of CtBP
and Ubc9 to PcG bodies. This work demonstrates a in which lysine 428 was altered to arginine (K428R; Fig-
novel activity at PcG bodies, and we speculate that PcG ure 2A). COS-1 cells were cotransfected with Flag-
complexes may exert their effects on transcription in CtBPK428R, T7-Ubc9, and either H6-SUMO-1 or -3 and
part by mediating the sumoylation of specific target pro- analyzed by Western blot. No sumoylated CtBPK428R was
teins. detected, indicating that lysine 428 is the principal lysine
utilized for SUMO conjugation (Figure 2B). This lysine
is present in the related CtBP2, but the surroundingResults
motif is absent (Figure 2A). No sumoylation of CtBP2
was detected when lysates from COS-1 cells trans-CtBP Is Sumoylated, In Vitro and In Vivo
CtBP contains a single sumoylation motif (see Figure fected with Fl-CtBP2, T7-Ubc9, and H6-SUMO-1 or -3
were analyzed by Western blot (Figure 2B). Thus, it ap-2A), suggesting that it may be a target for sumoylation.
To determine whether CtBP is a potential substrate, pears that the motif surrounding lysine 428 is important
for efficient sumoylation. Since lysine 428 appeared topurified bacterially expressed T7-CtBP was incubated
with recombinant Aos1/Uba2 (E1), Ubc9, and SUMO-1 be the major sumoylation site in CtBP, the additional
bands observed in Figure 1C are likely the result of polyin the presence of ATP. Reactions were terminated by
the addition of SDS-PAGE loading buffer and analyzed sumoylation of CtBP at lysine 428. However, we cannot
rule out the possibility that an initial sumoylation eventby Western blot with a T7-specific antibody to detect
CtBP. When recombinant E1, Ubc9, and SUMO-1 were at lysine 428 is required for subsequent modification of
other lysines within CtBP.all present, a slower migrating band was observed that
is consistent with the conjugation of SUMO-1 to CtBP To determine whether either CtBP or CtBP2 was able
to interact with Ubc9, COS-1 cells were transfected with(Figure 1A). This band was not present when either the
E1, Ubc9, or SUMO-1 was absent from the reaction, expression vectors encoding Fl-CtBP, Fl-CtBP2 or Fl-
CtBPK428R, and T7-Ubc9. Flag proteins were precipitatedsuggesting that CtBP can be sumoylated and indicating
that CtBP minimally requires these proteins for sumo- from cell lysates and Western blotted to detect copreci-
pitating T7-Ubc9. Surprisingly, CtBP, CtBP2, and CtBPK428Rylation.
To determine whether CtBP can be sumoylated in all associated with Ubc9, even though only CtBP is mod-
ified by SUMO (Figure 2C). Thus, it appears that determi-vivo, COS-1 cells were cotransfected with expression
constructs encoding T7-tagged CtBP and six-histidine- nants outside the sumoylation motif contribute to inter-
action with Ubc9.(H6)-tagged SUMO-1 or -3. Cell lysates were separated
Polycomb and SUMO
129
Sumoylated CtBP Is Associated with Pc2
CtBP may have both nuclear and non-nuclear functions,
and localizes to nucleus and cytoplasm (Criqui-Filipe et
al., 1999; Weigert et al., 1999; Turner and Crossley,
2001). The polycomb group protein, Pc2, can recruit
CtBP to PcG bodies within the nucleus (Sewalt et al.,
1999). We, therefore, wished to determine where in the
cell sumoylated CtBP was localized. We created tagged
versions of CtBP and Pc2, which were fused to color-
shifted enhanced green fluorescent protein variants (ei-
ther cyan or yellow; CFP or YFP). As shown in Figure
3A, when visualized by fluorescence microscopy, CFP-
CtBP was present in both the nucleus and cytoplasm
of COS-1 cells. However, in the presence of coex-
pressed T7-Pc2, a significant proportion of the CFP-
CtBP localized to nuclear foci. Visualization of CFP-
CtBP and YFP-Pc2 in the same cells clearly revealed
that the two proteins colocalize (Figure 3B). Thus, in
live cells, CFP-CtBP was recruited to PcG bodies by
coexpression of Pc2.
Since only a proportion of the CtBP is modified by
SUMO, we first sought to determine biochemically the
localization of this fraction of CtBP. Cells were treated
with digitonin to selectively permeabilize the plasma
membrane. After removal of the cytosol cells were
treated with 1% NP40 to dissolve the nuclear membrane
and release soluble nuclear proteins. The remaining in-
soluble cellular material was designated as the pellet
fraction. Digitonin soluble, NP40 soluble, and pellet (in-
soluble) fractions were analyzed by Western blot with
a T7 antibody to detect transfected CtBP. CtBP was
primarily localized in the digitonin and NP40 soluble
fractions, with some CtBP in the pellet (Figure 3C), con-
sistent with its localization to nucleus and cytoplasm.
When COS-1 cells were transfected with T7-CtBP, Fl-
Ubc9, and H6-SUMO-3, the majority of SUMO-3-conju-
gated CtBP was in the NP40 fraction, suggesting that
it was present in a soluble nuclear fraction (Figure 3C).
When Flag-Pc2 was coexpressed with T7-CtBP, Fl-
Ubc9, and H6-SUMO-3, virtually all of the SUMO-3-con-
jugated CtBP was present in the insoluble nuclear frac-
tion (pellet), together with the majority of the Pc2 (Figure
3D). Interestingly, coexpression of Pc2 also appeared
to increase the amount of SUMO-3 conjugated to CtBP.
These results suggest that sumoylated CtBP is associ-
analyzed by Western blot with a T7 antibody. The positions of un-
modified and SUMO-1 modified CtBP are shown.
(B) COS-1 cells were transfected with T7-CtBP, Flag-Ubc9, and H6-
SUMO-1 or -3 expression constructs. Proteins were separated by
SDS-PAGE and analyzed by Western blot with a T7 antibody. The
positions of sumoylated forms of CtBP are shown.
(C) COS-1 cells were transfected with H6-CtBP, T7-Ubc9, and Flag-
SUMO-1 or -3 expression constructs as indicated. Cells were lysed
in 6 M guanidine-HCl, proteins were purified on cobalt agarose and
Western blotted with a Flag antibody. The positions of sumoylated
forms of CtBP are indicated. The white arrow shows where unmodi-
fied CtBP would be expected to migrate. Lower panel: 10% of the
cells were analyzed by direct Western blot using a Flag antibody.
(D) Proteins were precipitated from HeLa cell lysates with antibodies
Figure 1. CtBP Is Sumoylated
specific for CtBP, CtBP2, or Flag (as indicated) and Western blotted
with a SUMO-1-specific antibody. The positions of CtBP-SUMO-1
(A) Purified T7-CtBP was incubated in the presence or absence of and the immunoglobulin heavy chain (HC) are shown. The positions
recombinant Aos1/Uba2 (E1), Ubc9, and SUMO-1. Proteins were of molecular weight markers (kD) are shown.
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Figure 2. CtBP Is Sumoylated at Lysine 428
(A) An amino acid alignment of the carboxy termini of CtBP and CtBP2 is shown, with the lysine to arginine mutant (K428R). The sumoylation
consensus is boxed.
(B) COS-1 cells were transfected with Fl-CtBP, Fl-CtBP2, or the K428R mutant and T7-Ubc9 and H6-SUMO as indicated. Proteins were
separated by SDS-PAGE and analyzed by Western blot using a Flag antibody.
(C) COS-1 cells were cotransfected with T7-Ubc9 and the indicated Flag-tagged CtBP expression vector. Proteins were precipitated with Flag
agarose and analyzed by Western blot with a T7 antibody. Expression of transfected proteins in the lysates is shown below. The bar denotes
immunoglobulin light chain.
ated with Pc2, and raise the possibility that Pc2 en- To further demonstrate that Pc2 is modified by SUMO,
bacterially expressed T7-Pc2 was purified on T7 aga-hances CtBP sumoylation.
rose and incubated with GST-SUMO-3, Ubc9, E1, and
ATP. As shown in Figure 4C, slower migrating forms ofPc2 Is Sumoylated
Coexpression of SUMO-3 and Ubc9 with Flag-Pc2 re- Pc2, corresponding to attachment of multiple SUMOs
to Pc2, were detected. When either SUMO-3, Ubc9, orsulted in the presence of multiple slower migrating Flag-
reactive bands, indicating that Pc2 may be sumoylated the E1 was absent, no modified Pc2 was observed.
Together, these results demonstrate that both CtBP and(Figure 3D). To test this possibility, whole cell extracts
from COS-1 cells that had been transfected with T7- Pc2 are sumoylated and that sumoylated CtBP appears
to be preferentially associated with Pc2.Pc2 and H6-SUMO-1 or -3 were Western blotted for
T7-Pc2. In addition to detecting Pc2, multiple slower
migrating bands were observed, suggesting the conju- Pc2 Localizes SUMO and Ubc9 to Nuclear Foci
Since Pc2 is sumoylated, we decided to use fluores-gation of multiple SUMOs to Pc2 (Figure 4A). The inten-
sity of these bands was not significantly enhanced by cence microscopy to determine the effect of coexpres-
sion of Pc2 on the subcellular localization of CFP-coexpression of Ubc9, suggesting that endogenous
Ubc9 levels were sufficient to sumoylate Pc2. SUMO-1. COS-1 cells transfected with CFP-SUMO-1
showed a dispersed nuclear distribution of CFP-As further evidence that the slower migrating bands
were sumoylated forms of Pc2, COS-1 cells were trans- SUMO-1, with some fluorescent signal present outside
the nucleus (Figure 5A). Coexpression of Fl-Pc2 resultedfected with T7-Pc2 and Fl-SUMO-1 or -3, and lysed in
6 M guanidine-HCl. Pc2 contains 12 consecutive histi- in the localization of much of the CFP-SUMO-1 to nu-
clear foci characteristic of PcG bodies (Figure 5A). Wedine residues, making it possible to purify T7-Pc2 with
cobalt agarose (Figure 4B, lower panel). After purifica- obtained similar results with CFP-SUMO-3 to those ob-
served with SUMO-1 (Figure 5D and data not shown).tion on cobalt agarose, proteins were Western blotted
to detect Flag-SUMO conjugated to Pc2. As expected, Fluorescence microscopy of COS-1 cells transfected
with YFP-Ubc9 indicated that it was localized primarilyunmodified Pc2 was not detected with the Flag anti-
body, but multiple slower migrating forms of Pc2 were to the nucleus, and coexpression of Pc2 resulted in the
recruitment of YFP-Ubc9 to nuclear foci (Figure 5B). Topresent (Figure 4B). In a parallel experiment, when cells
were transfected with T7-Pc2 alone and proteins puri- confirm that the foci observed with YFP-Ubc9 are PcG
bodies, we coexpressed YFP-Ubc9 and CFP-Pc2. Asfied on cobalt agarose, conjugation of endogenous
SUMO-1 to T7-Pc2 was detected (Figure 4B, right panel). shown in Figure 5C, a significant proportion of both
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Figure 3. CtBP-SUMO Associates with Pc2
(A) COS-1 cells were transfected with a CFP-CtBP expression vector. After 24 hr, cells were stained with Hoechst and live cells were visualized.
CFP-CtBP was expressed in the absence (upper) or presence (lower) of T7-Pc2. CFP and Hoechst images are shown. Scale bar  10 m.
(B) CFP-CtBP was coexpressed with YFP-Pc2. Hoechst, cyan, and yellow images are shown, with the merged image of CFP and YFP
fluorescence (overlay).
(C and D) COS-1 cells were transfected with the indicated expression constructs and partitioned into digitonin soluble (“D”), NP40 soluble
(“N”), and pellet (“P”) fractions, which were analyzed for T7-CtBP or Fl-Pc2 by Western blot.
proteins clearly colocalized to nuclear foci. Together, same subnuclear compartment. As an E3, Pc2 would
be expected to enhance CtBP sumoylation. To test this,these data suggest a novel subnuclear localization of
SUMO and Ubc9 to PcG bodies, dependent on Pc2. COS-1 cells were transfected with T7-CtBP and H6-
SUMO-1 or 3, with and without Fl-Pc2, and cell lysatesPML localizes at subnuclear domains (PML bodies)
and is modified by SUMO-1 (Muller et al., 1998; Lalle- were Western blotted to detect T7-CtBP. Pc2 clearly
enhanced the amount of SUMO-1 or SUMO-3 conju-mand-Breitenbach et al., 2001). We, therefore, wanted
to know whether Pc2 localized SUMO to nuclear do- gated to CtBP and was able to further increase sumoyla-
tion over that seen with Ubc9 coexpression (Figure 6B).mains that were distinct from PML bodies. COS-1 cells
were cotransfected with CFP-Pc2 and a YFP-PML ex- In addition, when these lysates were probed for Pc2,
sumoylated forms of Pc2 were detected. Interestingly,pression construct. As shown in Figure 5D, YFP-PML
and CFP-Pc2 both form subnuclear foci, but do not Pc2 is a chromodomain protein, which shares no signifi-
cant homology with known E3 ligases. Removal of thecolocalize. In contrast, cotransfection with YFP-PML
and CFP-SUMO-3 resulted in clear colocalization of chromodomain of Pc2 (construct 68–558) did not affect
enhancement of CtBP sumoylation, whereas, furtherSUMO-3 with PML bodies. We then wanted to determine
whether PML and Pc2 recruited SUMO to separate sites. truncation to amino acid 401 abolished this activity (Fig-
ure 6C). Since both constructs interact with CtBP (dataCFP-SUMO-3 localized to an increased number of foci
within the nucleus of cells expressing Pc2, and only a not shown), the region between amino acids 68 and 401
may be required for Ubc9 interaction.proportion of these foci colocalized with YFP-PML (Fig-
ure 5D). Thus, both PML and PcG bodies may be distinct To further demonstrate that Pc2 increased sumoyla-
tion of CtBP, COS-1 cells were cotransfected with H6-sites of SUMO modification within the nucleus.
CtBP, T7-Pc2, and Fl-SUMO, lysed in 6 M guanidine-HCl
and proteins were purified on cobalt agarose. WesternPc2 Is a SUMO E3
SUMO E3 ligases, like RING domain ubiquitin E3s, do not blotting with a Flag antibody to detect sumoylated CtBP
demonstrated that Pc2 expression increased thepossess intrinsic enzymatic activity, but act as adapters
which bring together the E2 (Ubc9) and the substrate amount of purified sumoylated H6-CtBP (Figure 6D).
Together, these results show that Pc2 recruits both(Hochstrasser, 2001; Jackson, 2001). As shown in Figure
6A, CFP-CtBP and YFP-Ubc9 show only partial colocali- Ubc9 and CtBP to PcG bodies and enhances sumoyla-
tion of CtBP, suggesting that Pc2 is at least a componentzation. However, when Pc2 is also coexpressed, both
CFP-CtBP and YFP-Ubc9 become colocalized to PcG of a SUMO E3 complex.
To determine whether Pc2 is a SUMO E3, we per-bodies. Thus, Pc2 is recruiting substrate and E2 to the
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of Ubc9, irrespective of Pc2 addition. We had observed
that although CtBP2 interacted with Ubc9, no sumo-
ylated CtBP2 was detected in vivo (see Figure 2). Sur-
prisingly, CtBP2 was sumoylated in vitro in the presence
of E1 and Ubc9 and this modification was significantly
enhanced by the addition of Pc2 (Figure 7B). We next
determined whether Pc2 expression would allow detec-
tion of CtBP2 sumoylation in vivo, by enhancing the
level of this modification. As shown in Figure 7C, coex-
pression of H6-SUMO-1 with either Ubc9 or Pc2 resulted
in efficient sumoylation of CtBP, but not of the CtBPK428R
mutant. Interestingly, although no sumoylated CtBP2
was observed in the presence of H6-SUMO-1 and Ubc9,
the coexpression of Pc2 and H6-SUMO-1 clearly in-
duced CtBP2 sumoylation (Figure 7C). Taken together,
these results demonstrate that Pc2 is a SUMO E3.
Discussion
We show that CtBP can be sumoylated, both in vivo
and in vitro, at a SUMO consensus motif. Importantly,
Pc2 clearly enhances sumoylation of CtBP, suggesting
that Pc2 represents a novel class of SUMO E3s. In addi-
tion, Pc2 can recruit both CtBP and Ubc9 to PcG bodies,
suggesting that these structures may function as cen-
ters of sumoylation within the nucleus.
A SUMO E3
Ubc9 is necessary and sufficient to attach SUMO to
numerous substrates. However, by analogy with ubiqui-
tination, SUMO E3s are likely to help determine sub-
strate specificity and enhance efficiency of sumoylation.
Ubiquitin E3s fall into two classes: HECT domain pro-
teins are true enzymes, which form a thioester bond
with ubiquitin prior to transferring it to the substrate. In
contrast, RING domain proteins act as adapters, bring-
ing together E2 and substrate (Laney and Hochstrasser,
1999). Two classes of SUMO E3 have been identified,
both of which contain RING-like domains and appear
to act as nonenzymatic adapters. In Siz1p and PIAS
proteins, the RING-like domains are required for E3 ac-
tivity (Johnson and Gupta, 2001; Kahyo et al., 2001;
Figure 4. Pc2 Is Sumoylated Sachdev et al., 2001; Schmidt and Muller, 2002) whereas
(A) COS-1 cells were transfected with the indicated expression con- the RING domain of RanBP2 is dispensable for E3 activ-
structs and cell lysates were analyzed by Western blot with a T7 ity (Pichler et al., 2002).
antibody.
Here, we demonstrate a novel function for Pc2, namely(B) Transfected COS-1 cells were lysed in guanidine-HCl, proteins
that it acts as a SUMO E3 for CtBP: Pc2 interacts withpurified on cobalt agarose, and analyzed by Western blot with Flag
both Ubc9 and with CtBP, concentrates both proteinsor T7 antibodies, or a SUMO-1 specific antibody (right panel). The
positions of Pc2 and sumoylated Pc2 are indicated, together with into PcG bodies and stimulates the transfer of SUMO
molecular weight (kD) markers. The white arrow indicates the ex- to CtBP. Importantly, purified Pc2 also enhanced CtBP
pected mobility of unmodified Pc2. sumoylation in vitro. Pc2 is analogous to other SUMO
(C) Bacterially expressed T7-Pc2 was incubated in the presence or
E3s, in that it acts as a nonenzymatic adaptor, but mayabsence of recombinant E1, Ubc9, and GST-SUMO-3 for 2 hr at
also have a more specialized function, since it causes30C. Proteins were analyzed by Western blot with a T7 antibody.
a stable colocalization of E2 and substrate. RanBP2,The positions of Pc2 and SUMO-3 modified Pc2 are shown.
acts as an E3 for Sp100, a protein which localizes to PML
bodies. In contrast to our data with Pc2, this suggests a
transient interaction of E2, E3, and substrate at the NPC,formed in vitro sumoylation assays with CtBP, using
limiting levels of Ubc9 in the presence or absence of possibly while the substrate is en route to its final loca-
tion in the nucleus (Wu et al., 1995; Sternsdorf et al.,purified bacterially expressed Pc2. As shown in Figure
7A, with Ubc9, only a small amount of sumoylated CtBP 1997; Pichler et al., 2002). Pc2 recruits both Ubc9 and
CtBP to PcG bodies, suggesting that PcG bodies maywas visible. However, addition of recombinant Pc2 to
the reaction resulted in a clear increase in sumoylated be a specific site of CtBP sumoylation. A second possi-
bility is that CtBP is itself part of an E3 complex whichCtBP. No modified CtBP was observed in the absence
Polycomb and SUMO
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Figure 5. Ubc9 and SUMO Localize to Poly-
comb Bodies
COS-1 cells were transfected with the indi-
cated expression vectors and fluorescence
visualized as in Figure 3.
(A) CFP-SUMO-1 was expressed alone or
with Flag-Pc2.
(B) YFP-Ubc9 was expressed alone or in the
presence of Flag Pc2. CFP or YFP and
Hoechst images are shown.
(C) YFP-tagged Ubc9 was coexpressed with
CFP-Pc2. The images are shown individually
and merged (overlay).
(D) YFP-tagged PML was coexpressed with
CFP-Pc2 (upper), or with CFP-SUMO-3 (mid-
dle). YFP-PML and CFP-SUMO-3 were coex-
pressed with Flag-tagged Pc2 (lower). Indi-
vidual YFP, CFP, and Hoechst images are
shown, together with the merged YFP and
CFP image (overlay). Scale bar  10 m.
recruits other proteins to PcG bodies to be sumoylated. absence of a targeting motif, a SUMO E3 can determine
substrate specificity. Thus, it appears that two factorsIt is also possible that other PcG proteins may be part
of a Pc2-containing E3 complex. It will now be of interest can contribute to substrate specificity: The presence
of a sumoylation motif within the substrate, and theto determine the importance of other PcG proteins for
sumoylation of CtBP or other substrates. presence of an appropriate E3 factor. That Pc2 can
enhance sumoylation of CtBP2 by Ubc9, suggests thatOur data demonstrate that Pc2 represents a novel
class of SUMO E3, which has no obvious sequence other potential SUMO substrates, which lack the tar-
geting motif may indeed be sumoylated in vivo, providedsimilarity to other known E3s, perhaps suggesting the
existence of other unrelated SUMO E3s. It is likely that the correct E3 is present.
multiple E3s will compete for interaction with Ubc9 and
recruit it to specific subcellular locations, resulting in A Novel Function for Polycomb Bodies
a high local concentration of E2 and substrate. Thus, We have demonstrated a novel enzymatic activity at
proteins like Pc2 may be important rate-limiting factors PcG complexes, which results in the sumoylation of at
in specific sumoylation pathways. least two proteins. Although purified recombinant Pc2
has E3 activity toward CtBP, it is possible that, since
Pc2 is part of a multimeric complex, other associatedNonconsensus SUMO Substrates
Many SUMO substrates, including CtBP, contain a con- PcG proteins may contribute to full E3 activity in vivo.
Pc2 recruits Ubc9 and SUMO, resulting in Pc2 sumoyla-sensus targeting motif, which is clearly an important
determinant of substrate specificity. We show that tion. This E2-E3 complex (Ubc9 and Pc2) efficiently su-
moylates CtBP, and may also modify other PcG proteinsCtBP2, which does not contain this motif, interacts with
Ubc9 and is sumoylated in vitro. However, in vivo su- within the complex. For example, Bmi-1 contains a
SUMO consensus site, is a component of PcG com-moylation of CtBP2 is much more dependent on Pc2
than is sumoylation of CtBP, suggesting that even in the plexes, and Bmi-1 interacts with Pc2 (Gunster et al.,
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Figure 6. Pc2 Enhances the Sumoylation of CtBP
(A) COS-1 cells were transfected and imaged as described in Figure 3. CFP-CtBP and YFP-Ubc9 were coexpressed in the absence or presence
of Flag-Pc2. Individual CFP and YFP images and the merged (overlay) are shown. Scale bar  10 m.
(B) COS-1 cells were transfected with T7-CtBP and expression constructs encoding Fl-Ubc9, Fl-Pc2, and H6-SUMO-1 or -3 as indicated and
analyzed for T7-CtBP by Western blot. Expression of Pc2 and Ubc9 is shown below.
(C) COS-1 cells were transfected with T7-CtBP, H6-SUMO-1 with the indicated Flag-Pc2 expression constructs, encoding amino acids 1–558
(full length), 68–558, or 401–558, and analyzed for T7-CtBP by Western blot.
(D) COS-1 cells were transfected with the indicated expression constructs, lysed in guanidine-HCl and H6-CtBP was purified on cobalt agarose.
Proteins were analyzed by Western blot with a Flag antibody. Expression of CtBP and Pc2 was monitored by direct Western.
1997). It is possible that sumoylation of a proportion of In summary, we show that Pc2 is a SUMO E3, and
PcG proteins is required for the integrity of PcG bodies. that sumoylation is likely to occur specifically at PcG
In this context, sumoylation of PML is required for its bodies. This identifies a novel function of this subnuclear
localization to PML bodies (Muller et al., 1998). Thus, compartment, and has implications for the regulation of
the formation of specific macromolecular complexes nuclear function and gene expression.
within the nucleus may require SUMO modification of
Experimental Proceduresthe proteins within them.
Alternatively, it is possible that one role of Pc2 is to
Cell Culture and Transfectionrecruit and modify specific target proteins involved in
COS-1 and HeLa cells were maintained in DMEM with 10% fetaltranscriptional regulation. CtBP is recruited to PcG bod-
bovine serum and transfected in 6-well plates or 60 mm dishes
ies by Pc2, and sumoylated CtBP preferentially associ- using LipofectAMINE (Life Technologies, Inc.).
ates with Pc2. Thus, CtBP may simply represent a sub-
strate for recruitment and sumoylation at PcG bodies. Plasmids
However, CtBP has been suggested to bridge interac- CtBP, CtBP2, Ubc9, SUMO-1, SUMO-3, and Pc2 were expressed
from modified pCMV5 plasmids that contained Flag, T7, or six histi-tions between multiple proteins involved in transcrip-
dine tags. Fluorescent protein fusions were expressed from pCS2tional regulation (Turner and Crossley, 2001; Chinna-
with amino terminal fusions to eCFP or eYFP. The CtBPK428R mutationdurai, 2002). It is, therefore, tempting to speculate that
was created by PCR and verified by sequence analysis. GST fusionsCtBP is part of the PcG sumoylation machine, which were expressed from pGEX-5TK or pGEX-4T1 (Amersham Phar-
recruits specific binding partners, to the larger PcG E3 macia) and T7 and six histidine fusions from pET21a (Novagen).
complex. These may then be sumoylated by Pc2-associ- Bacterial histidine tagged CtBP2 was expressed from pParallel. A
Pc2 construct was engineered by PCR which lacked the internalated Ubc9.
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poly-histidine stretch (aa 381–399) and was truncated at codon 529,
and was expressed from within pParallel.
Coimmunoprecipitation and Western Blot
COS-1 cells were lysed by sonication in phosphate-buffered saline
with 1% NP40 (PBS-N) and protease inhibitors (protease inhibitor
mixture; Roche). Following removal of cell debris by centrifugation,
lysates were immunoprecipitated with Flag-agarose (Sigma). After
washing, proteins were separated by SDS-PAGE and transferred to
Immobilon-P (Millipore). Blots were incubated with anti-T7 antisera
(Novagen) and HRP-conjugated goat anti-mouse antibody (Pierce).
Proteins were visualized by ECL (Amersham Pharmacia). For direct
Western, COS-1 cells were lysed in SDS-loading buffer and analyzed
with the appropriate antisera (anti-Flag M2, Sigma; anti-T7 tag, No-
vagen). For analysis of endogenous CtBP, HeLa cells (one confluent
150 mm plate per immunoprecipitation) were lysed in 500 l PBS-N
with 1% SDS, protease inhibitors and 10 mM N-ethylmaleimide.
Samples were diluted with 4.5 ml PBS-N. Following centrifugation,
lysates were pre-cleared with protein A and protein G Sepharose
(Pierce). Proteins were precipitated with 1 g antibody (anti-CtBP
or CtBP2; BD Biosciences or anti-Flag; Sigma), washed four times
alternating between RIPA buffer (150 mM NaCl, 1% NP40, 50 mM
Tris-HCl [pH 8.0], and 0.1% SDS) and PBS-N, and Western blotted
with a SUMO-1 antibody (Zymed).
Cobalt Affinity Purification
COS-1 cells were lysed in 6 M Guanidine-HCl, 50 mM NaH2PO4 (pH
8.0), 10 mM Tris-HCl (pH 8.0), and 100 mM NaCl. H6 tagged proteins
were bound to Talon Resin (Clontech) by rocking for 2 hr. Beads
were washed 4 times for 30 min with 8 M Urea, 50 mM NaH2PO4
(pH 7.0), and 100mM NaCl.
Recombinant Proteins and In Vitro Sumoylation
T7-CtBP-H6 was expressed in BL21-CodonPlus-RP (Stratagene);
H6-CtBP2 was expressed in BL21 and proteins were purified on a
1 ml Hi-Trap CoCl2 column (Amersham Pharmacia), using a continu-
ous imidazole gradient. GST-SUMO-1 and -3 and GST-Ubc9 were
purified from BL21 on glutathione agarose. GST was removed by
cleavage with Factor X or Thrombin and the protease removed by
affinity chromatography. Alternatively, bound proteins were eluted
using 10 mM glutathione. The SUMO E1 (Aos1/Uba2 dimer) was
expressed in BL21-CodonPlus-RIL (Stratagene) and purified via an
H6 tag on Uba2. Proteins were purified as for H6-CtBP2, followed
by size exclusion chromatography on a Superdex 200 column
(Amersham Pharmacia). T7-tagged Pc2 was purified from BL21-
CodonPlus-RP on T7-agarose (Novagen). H6 tagged Pc2 (amino
acids 2-381:400-529) was expressed in BL21 and purified by cobalt
affinity chromatography and size exclusion chromatography as for
Aos1/Uba2. In vitro sumoylation reactions were performed essen-
tially as described (Schmidt and Muller, 2002): 200 ng of T7-CtBP-
H6 were incubated for 2 hr at 30C in 20 l (50 mM Tris [pH 7.5], 5
mM MgCl2, and 2 mM ATP) with 2 g of SUMO-1, 500 ng of Ubc9,
and 100 ng of Aos1/Uba2. Reactions were analyzed by Western
blot. For analysis of the effect of Pc2 on CtBP sumoylation, reactions
were as above except that 75 ng Ubc9 was used and Pc2 (0.5–15ng)
was added.
Biochemical Fractionation
Transfected COS-1 cells were permeabilized with transport buffer
Figure 7. Pc2 Is a SUMO E3
(TB: 20 mM HEPES [pH 7.4], 110 mM potassium acetate, 2 mM
magnesium acetate, and 0.5 mM EGTA) with 0.005% digitonin, pro-
tease inhibitors, and 10 mM N-ethylmaleimide, for 5 min. The cytosol(A) Purified T7-CtBP was incubated with recombinant Aos1/Uba2
fraction was removed and cells were washed twice with TB, prior(E1) and SUMO-1, with or without 75 ng Ubc9, with 0, 3, or 15 ng
to solubilization in TB with 1% NP40. NP40 soluble and pellet frac-of purified Pc2, as indicated. Proteins were analyzed by Western
tions were separated by centrifugation.blot with a T7 antibody. The position of CtBP and sumoylated CtBP
are indicated.
(B) Bacterial H6-CtBP2 was incubated with E1 and SUMO-3 with or
without 75 ng Ubc9 and Pc2 (0.5 or 1 ng) was added as indicated.
The positions of modified and unmodified CtBP2 are shown. were analyzed by Western blot with a Flag antibody. The position
(C) COS-1 cells were transfected with expression vectors encoding of modified and unmodified forms of CtBP (upper), CtBPK428R (mid-
either Flag-CtBP, Flag-CtBPK428R, or Flag-CtBP2 together with H6- dle), and CtBP2 (lower) are shown. The positions of molecular weight
SUMO-1, and either T7-Ubc9 or T7-Pc2, as indicated. Cell lysates markers are indicated.
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Live Cell Imaging and Azorin, F. (2000). The GAGA factor of Drosophila interacts with
SAP18, a Sin3-associated polypeptide. EMBO Rep. 1, 253–259.COS-1 cells were split onto 4-well chamber slides (Nunc) and trans-
fected with cyan or yellow fluorescent protein (eCFP or eYFP; BD Francis, N.J., Saurin, A.J., Shao, Z., and Kingston, R.E. (2001). Re-
Biosciences) tagged fusion proteins using Fugene 6 (Roche). After constitution of a functional core polycomb repressive complex. Mol.
22–26 hr, cells were stained with 0.5 g/ml Hoechst 33342 (Sigma) Cell 8, 545–556.
for 20 min at 37C. Cells were imaged using a Zeiss Axiovert 135T
Gerasimova, T.I., and Corces, V.G. (1998). Polycomb and trithorax
inverted fluorescence microscope on a heated stage with CFP and
group proteins mediate the function of a chromatin insulator. Cell
YFP filter sets (Omega Opticals). Hoechst staining was visualized
92, 511–521.
with a DAPI filter set. Images were visualized and captured with a
Gunster, M.J., Raaphorst, F.M., Hamer, K.M., den Blaauwen, J.L.,Zeiss 32/0.40 objective and a Hamamatsu Orca II cooled CCD
Fieret, E., Meijer, C.J., and Otte, A.P. (2001). Differential expressioncamera controlled by Isee software (Inovision). Images were converted
of human Polycomb group proteins in various tissues and cell types.to 8 bit .tif files using Isee and manipulated in Photoshop 6.0.
J. Cell. Biochem. 81, 129–143.
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